There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.

Clinical Trials

Clinical Trial

Other

Status: Recruiting
Participants: 20000
Start Date: July 2013

A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Clinical Trial

Drug

Status: Active, not recruiting
Study Type: Drug
Participants: 18
Start Date: October 2010

A Phase I Study Investigating the Combination of RAD001 With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 50
Start Date: February 8, 2010

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Clinical Trial

Drug

Status: Active, not recruiting
Study Type: Drug
Participants: 717
Start Date: April 2008

A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)

View All Clinical Trials